SECsense Logo

Medtronic plc 8-K Report: Key Insights on Debt and Corporate Changes

$MDT
Form 8-K
Filed on: 2025-02-18
Source
Medtronic plc 8-K Report: Key Insights on Debt and Corporate Changes

Based on the provided XML section of the financial report, the key information can be summarized as follows:

  1. Company Information:
  • Entity Name: Medtronic plc
  • CIK: 0001613103
  • Address: Building Two Parkmore Business Park West, Galway, IE
  • Contact Number: 353 1 438-1700
  1. Filing Details:
  • Date of Filing: February 18, 2025
  • Form Type: 8-K (a report of unscheduled material events or corporate changes)
  1. Securities Information:
  • Ordinary Shares:
    • Par Value: $0.0001
    • Ticker Symbol: MDT (NYSE)
  • Senior Notes Issued:
    • 0.250% Senior Notes due 2025 (Ticker: MDT/25)
    • 0.000% Senior Notes due 2025 (Ticker: MDT/25A)
    • 2.625% Senior Notes due 2025 (Ticker: MDT/25B)
    • 1.125% Senior Notes due 2027 (Ticker: MDT/27)
    • 0.375% Senior Notes due 2028 (Ticker: MDT/28)
    • 3.000% Senior Notes due 2028 (Ticker: MDT/28A)
    • 3.650% Senior Notes due 2029 (Ticker: MDT/29)
    • 1.625% Senior Notes due 2031 (Ticker: MDT/31)
    • 1.000% Senior Notes due 2031 (Ticker: MDT/31A)
    • 3.125% Senior Notes due 2031 (Ticker: MDT/31B)
    • 0.750% Senior Notes due 2032 (Ticker: MDT/32)
    • 3.375% Senior Notes due 2034 (Ticker: MDT/34)
    • 3.875% Senior Notes due 2036 (Ticker: MDT/36)
    • 2.250% Senior Notes due 2039 (Ticker: MDT/39A)
    • 1.500% Senior Notes due 2039 (Ticker: MDT/39B)
    • 1.375% Senior Notes due 2040 (Ticker: MDT/40A)
    • 4.150% Senior Notes due 2043 (Ticker: MDT/43A)
    • 1.750% Senior Notes due 2049 (Ticker: MDT/49)
    • 1.625% Senior Notes due 2050 (Ticker: MDT/50)
    • 4.150% Senior Notes due 2053 (Ticker: MDT/53)
  1. Context and Period:
  • All financial data provided is for the period starting and ending on February 18, 2025.

Insights:

  • Medtronic is actively managing its debt profile with multiple senior notes due at various intervals, indicating a strategy of staggered maturities which can help with cash flow management.
  • The issuance of both fixed-rate and zero-coupon notes allows flexibility in interest expense management.
  • The timing of this filing (8-K) suggests that it may be related to significant corporate events, such as debt issuance or changes in capital structure, which could impact investor sentiment and stock performance.

This analysis provides a snapshot of Medtronic's financial obligations and corporate structure as of the reporting date.